Gastroplasty

Endoscopic sleeve gastroplasty in patients with nonalcoholic steatohepatitis vs. life-style intervention alone was safe and effective for achieving weight loss correlated with significant improvements, according to a presentation at the International Liver Congress.

A recent study showed that Entyvio was associated with higher rates of ulcerative colitis remission than anti-TNF agents. It was the top story in gastroenterology last week.

Patients with obesity treated with endoscopic sleeve gastroplasty achieved durable results for at least 5 year after the procedure, according to study results.

Healio Gastroenterology and Liver Disease presents the following reports on the most recent research in endoscopy.

Currently, gastroenterologists and other physicians have quite a few options to treat overweight and obesity, but at times that is overwhelming.

Before 2015, managing obesity was the realm of other specialties. Although gastroenterologists have traditionally dealt with some of the comorbidities of obesity, they were not in position to target the root cause and provide relief in the form of weight management. That changed with the clinical introduction and FDA approval of several devices and procedures for the endoscopic management of obesity and metabolic disease, putting GIs right in the middle of the obesity epidemic.